In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression

Abstract

Tacrolimus treatment reduces the ability of DC to stimulate T cells and the impaired production of DC-derived IP-10 (CXCL10) and IL-12 might play a role in the immunosuppressive action of tacrolimus.